Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases

Journal of B.U.ON.

Volumn 11, Issue 4, 2006, Pages 485-489

  Chloraki Bobota, Antigoni ^a,b   Megalakaki, C ^a   Repousis, P ^a   Chalkiopoulou, Ir ^a   Lalaki, I ^a   Trafalis, D T ^a   Athanassiou, A E ^a   Mitsouli Mentzikof, Chr ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Anti ds DNA antibodies; Anti ENA; Antinuclear antibodies; Lymphoma; Lymphoproliferative diseases; Rheumatic syndromes

Indexed keywords

ANTINUCLEAR ANTIBODY; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOUBLE STRANDED DNA ANTIBODY; DOXORUBICIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOXANTRONE; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; VINCRISTINE; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; DNA; INTERMEDIATE FILAMENT PROTEIN;

ADULT; AGED; ARTHRALGIA; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMORBIDITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREQUENCY ANALYSIS; HODGKIN DISEASE; HUMAN; IMMUNOFLUORESCENCE; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MORNING STIFFNESS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; MULTIPLE CYCLE TREATMENT; MYELOMA; NEPHELOMETRY; NONHODGKIN LYMPHOMA; PREVALENCE; RHEUMATIC DISEASE; UTERUS CARCINOMA; ADOLESCENT; BLOOD; IMMUNOLOGY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SYNDROME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; AUTOANTIBODIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; PREVALENCE; RHEUMATIC DISEASES; SENSITIVITY AND SPECIFICITY; SYNDROME;

EID: 33947509689     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Abbas AK, Lichtman AH, Pober JS (eds). Cellular and Molecular Immunology (4th edt). WB Saunders Co, Philadelphia, 2000.
2. Gergely L, Danko A, Csipo I et al. Antibodies against extractable nuclear antigen in non-Hodgkin's lymphoma patients. Scand J Immun 2005; 61:343-346.
3. Scofield RH. Autoantibodies as predictors of disease. Lancet 2004; 8:1544-1546.
4. Swissa M, Cohen Y, Shoenfeld Y. Autoantibodies in the sera of patients with lymphoma. Leuk Lymphoma 1992; 7:117-122.
5. Timuragaoglu A, Duman A, Ongut G, Saka O, Karadogan I. The significance of autoantibodies in non Hodgkin's lymphoma. Leuk Lymphoma 2000; 40:119-122.
6. Andrianakos A, Trontzas P, Christoyannis F et al. Prevalence of rheumatic diseases in Greece. A cross-selectional population based epidemiological study. The ESORDIG Study. J Rheumatol 2003; 30:1589-1601.
7. Kassan SS, Thomas TL, Moutsopoulos HM et al. Increased risk of lymphoma in sicca syndrome. Arch Inter Med 1978; 89:888-892.
8. Sultan SM, Ioannou Y, Isenberg DA. Is there an association of malignancy with SLE? Rheumatology 2000; 39:1147-1152.
9. Conaghan PG, Brooks PM. Rheumatic manifestations of malignancy. Curr Opin Rheumatol 1994; 6:105-110.
10. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006; 18:129-134.
11. Smedby KE, Hjalgrim H, Askling J et al. Autoimmune and chronic inflammatory disorders and risk of NHL by subtype. J Natl Cancer Inst 2006; 98:51-60.
12. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a metaanalysis. Ach Intern Med 2005; 165:1233-1234.
13. Bjornadal L, Lofstrom B, Yin L, Lundberg IE, Ekbom A. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31:66-71.
14. Valesini G, Priori R, Bavoillot D et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol 1997; 24:2376-2380.
15. Purves WK, Orians GH, Heller HC, Sadava D (eds). Life, The Science of Biology (5th edn). Sinauer, Freeman WH and Co, 1998.
16. Dellagi K, Brouet JC, Perreau J, Paulin D. Human monoclonal IgM with autoantibody activity against intermediate filaments. Proc Natl Acad Sci USA 1982; 79:446-450.